Phosphatidylethanol is Superior to Carbohydrate‐Deficient Transferrin and γ‐Glutamyltransferase as an Alcohol Marker and is a Reliable Estimate of Alcohol Consumption Level
Authors:
- 27 October 2015
- journal article
- research article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 39 (11) , 2200-2208
Abstract
Background: In clinical practice as well as research situations, it is of great importance to get reliable information about a patient's alcohol consumption. The aim of the study was to investigate the correlation of alcohol biomarkers (phosphatidylethanol [PEth], carbohydrate‐deficient transferrin [CDT], γ‐glutamyltransferase, aspartate aminotransferase, and alanine aminotransferase) to retrospective as well as diary‐based alcohol self‐reports and to examine whether it is possible to correlate a biomarker result to a more precise level of alcohol consumption.Methods: One hundred and sixty alcohol‐dependent patients were included in a randomized, placebo‐controlled clinical trial of pharmacotherapy for alcohol dependence, of which 115 (76 men and 39 women) completed the study. Retrospective alcohol consumption data were collected at baseline, and alcohol diaries were used during the study. Blood samples for determination of alcohol biomarkers were collected on 5 occasions during the study.Results: PEth and CDT showed a better correlation with alcohol consumption documented in the diary (PEth rs = 0.56 and CDT rs = 0.35) than with retrospective consumption data (PEth rs = 0.23 and CDT rs = 0.22). An even higher correlation (rs = 0.63) was seen between the 2 alcohol biomarkers PEth and CDT. At all consumption levels, PEth had the highest sensitivity of all biomarkers studied.Conclusions: PEth was the biomarker with the best correlation to self‐reported alcohol consumption. PEth was superior to CDT owing to its substantially higher sensitivity but also due to its closer correlation to self‐report. PEth values can be translated into an approximate level of alcohol consumption and PEth appears to be a more reliable measure of alcohol consumption than self‐reports.Keywords
Funding Information
- Pfizer (4477, 2576)
- Fredrik och Ingrid Thurings Stiftelse
- Hjärnfonden
- Medicinska Forskningsrådet (4477, 2576)
- Stiftelserna Wilhelm och Martina Lundgrens
This publication has 48 references indexed in Scilit:
- Phosphatidylethanol: The Potential Role in Further Evaluating Low Positive Urinary Ethyl Glucuronide and Ethyl Sulfate ResultsAlcohol, Clinical and Experimental Research, 2013
- Assessing the drinking status of liver transplant patients with alcoholic liver diseaseLiver Transplantation, 2013
- Formation of Phosphatidylethanol and Its Subsequent Elimination During an Extensive Drinking Experiment Over 5 DaysAlcohol, Clinical and Experimental Research, 2012
- Phosphatidylethanol (PEth) as a Biomarker of Alcohol Consumption in HIV‐Positive Patients in Sub‐Saharan AfricaAlcohol, Clinical and Experimental Research, 2011
- Detection of Phosphatidylethanol (PEth) in the Blood of Drivers in an Alcohol Ignition Interlock ProgramTraffic Injury Prevention, 2011
- Phosphatidylethanol and Alcohol Consumption in Reproductive Age WomenAlcohol, Clinical and Experimental Research, 2010
- Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptivesAddiction, 2010
- Preliminary Evaluation of Phosphatidylethanol and Alcohol Consumption in Patients with Liver Disease and HypertensionAlcohol and Alcoholism, 2009
- Phosphatidylethanol formation in rat organs after ethanol treatmentBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- An abnormal phospholipid in rat organs after ethanol treatmentFEBS Letters, 1983